Advertisement
KYMR vs WVE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and WVE is a Hold.
KYMR in upward trend: 10-day moving average crossed above 50-day moving average on October 30, 2026
The 10-day moving average for KYMR crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on KYMR as a result. In 63 of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for KYMR just turned positive on October 20, 2026. Looking at past instances where KYMR's MACD turned positive, the stock continued to rise in 31 of 43 cases over the following month. The odds of a continued upward trend are 72%.
KYMR moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where KYMR advanced for three days, in 238 of 291 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 144 of 183 cases where KYMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KYMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
KYMR broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.002) is normal, around the industry mean (3.051). P/E Ratio (-39.105) is within average values for comparable stocks, (-0.872). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (125.677) among similar stocks. P/S Ratio (103.093) is also within normal values, averaging (439.647).
The Tickeron Seasonality Score of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. KYMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 66 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
WVE's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for WVE turned positive on October 19, 2026. Looking at past instances where WVE's MACD turned positive, the stock continued to rise in 48 of 55 cases over the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where WVE's RSI Indicator exited the oversold zone, 20 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on WVE as a result. In 63 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
Following a +13.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where WVE advanced for three days, in 207 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 56 of 59 cases where WVE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
WVE broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for WVE entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.555) is normal, around the industry mean (3.051). P/E Ratio (-3.315) is within average values for comparable stocks, (-0.872). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (125.677) among similar stocks. P/S Ratio (12.953) is also within normal values, averaging (439.647).
The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. WVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
KYMR | WVE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 35 | 11 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | 29 Undervalued | |
PROFIT vs RISK RATING 1..100 | 38 | 100 | |
SMR RATING 1..100 | 95 | 98 | |
PRICE GROWTH RATING 1..100 | 35 | 82 | |
P/E GROWTH RATING 1..100 | 66 | 14 | |
SEASONALITY SCORE 1..100 | 31 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
KYMR's Valuation (6) in the null industry is in the same range as WVE (29) in the Biotechnology industry. This means that KYMR’s stock grew similarly to WVE’s over the last 12 months.
KYMR's Profit vs Risk Rating (38) in the null industry is somewhat better than the same rating for WVE (100) in the Biotechnology industry. This means that KYMR’s stock grew somewhat faster than WVE’s over the last 12 months.
KYMR's SMR Rating (95) in the null industry is in the same range as WVE (98) in the Biotechnology industry. This means that KYMR’s stock grew similarly to WVE’s over the last 12 months.
KYMR's Price Growth Rating (35) in the null industry is somewhat better than the same rating for WVE (82) in the Biotechnology industry. This means that KYMR’s stock grew somewhat faster than WVE’s over the last 12 months.
WVE's P/E Growth Rating (14) in the Biotechnology industry is somewhat better than the same rating for KYMR (66) in the null industry. This means that WVE’s stock grew somewhat faster than KYMR’s over the last 12 months.
| KYMR | WVE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | 2 days ago 80% |
| Stochastic ODDS (%) | 2 days ago 80% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 83% | 2 days ago 79% |
| MACD ODDS (%) | 2 days ago 72% | 2 days ago 87% |
| TrendWeek ODDS (%) | 2 days ago 78% | 2 days ago 80% |
| TrendMonth ODDS (%) | 2 days ago 78% | 2 days ago 85% |
| Advances ODDS (%) | 3 days ago 82% | 8 days ago 76% |
| Declines ODDS (%) | 13 days ago 86% | 3 days ago 86% |
| BollingerBands ODDS (%) | 2 days ago 78% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 79% | 2 days ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KYMR’s FA Score shows that 1 FA rating(s) are green while WVE’s FA Score has 2 green FA rating(s).
- KYMR’s FA Score: 1 green, 4 red.
- WVE’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KYMR’s TA Score shows that 6 TA indicator(s) are bullish while WVE’s TA Score has 4 bullish TA indicator(s).
- KYMR’s TA Score: 6 bullish, 4 bearish.
- WVE’s TA Score: 4 bullish, 4 bearish.
Price Growth
KYMR (@Biotechnology) experienced а +8.10% price change this week, while WVE (@Biotechnology) price change was +3.77% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -3.87%. For the same industry, the average monthly price growth was -11.47%, and the average quarterly price growth was -16.77%.
Reported Earning Dates
KYMR is expected to report earnings on Feb 25, 2027.
Industries' Descriptions
@Biotechnology (-3.87% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
KYMR and
Correlation & Price change
A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with GPCR. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then GPCR could also see price increases.
| Ticker / NAME | Correlation To KYMR | 1D Price Change % | ||
|---|---|---|---|---|
| KYMR | 100% | -0.33% | ||
| GPCR - KYMR | 63% Loosely correlated | -0.59% | ||
| NRIX - KYMR | 58% Loosely correlated | +0.47% | ||
| WVE - KYMR | 52% Loosely correlated | +1.70% | ||
| CGEM - KYMR | 44% Loosely correlated | +5.49% | ||
| REPL - KYMR | 44% Loosely correlated | +5.95% | ||
More | ||||
WVE and
Correlation & Price change
A.I.dvisor indicates that over the last year, WVE has been loosely correlated with GPCR. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then GPCR could also see price increases.
| Ticker / NAME | Correlation To WVE | 1D Price Change % | ||
|---|---|---|---|---|
| WVE | 100% | +1.70% | ||
| GPCR - WVE | 63% Loosely correlated | -0.59% | ||
| KYMR - WVE | 53% Loosely correlated | -0.33% | ||
| IBIO - WVE | 50% Loosely correlated | +2.95% | ||
| FRMM - WVE | 44% Loosely correlated | +4.89% | ||
| ELVN - WVE | 41% Loosely correlated | +0.45% | ||
More | ||||